Physician profile
Anuj Patel
NPI 1912340613
$122,420.87
in general payments reported to CMS, 2019-2025
18 companies · $70K in 2025
The $70K reported for 2025 was more than what 90% of Orthopaedic Surgery of The Spine providers received nationally (typical 2025 total: $2,116).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,816 · 2020: $640 · 2021: $3,208 · 2022: $6,769 · 2023: $21K · 2024: $16K · 2025: $70K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $69K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $20K · Travel and Lodging: $12K · Food and Beverage: $5,789.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $68,687.50 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $20,137.50 |
| Travel and Lodging | $12,374.89 |
| Food and Beverage | $5,789.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Globus Medical, INC. | $43,387.74 | 2022-2025 | Xlif, Excelsius Gps, Excelsiusgps Robotic Navigation System |
| Stryker Corporation | $32,333.62 | 2019-2025 | Sonopet Iq, Core, Everest Spinal System |
| Medtronic, INC. | $27,106.93 | 2022-2025 | Unid_pass, Pivox Oblique Lateral Spinal System, Anteralign Spinal System With Titan Nanolock Surface Technology |
| Nuvasive, INC. | $8,336.07 | 2019-2023 | Xlif, Pulse, Simplify Cervical Artificial Disc |
| Kuros Biosciences USA, INC | $4,230.95 | 2024-2025 | Magnetos |
| Alphatec Spine, INC | $4,211.24 | 2022-2023 | Other - Miscellaneous, Battalion Tlif - PC |
| Medtronic USA, INC. | $1,018.81 | 2019-2020 | |
| Depuy Synthes Sales INC. | $571.06 | 2019-2023 | Teligen |
| Abbott Laboratories | $333.54 | 2021-2024 | Proclaim, Eterna |
| Medacta USA, INC. | $208.85 | 2019 | |
| Si-Bone, INC. | $173.04 | 2022 | |
| Mml US, INC. | $161.85 | 2022 | |
| Orthofix Medical, INC. | $102.49 | 2024-2025 | Trinity Elite |
| Arteriocyte Medical Systems, INC. | $89.48 | 2024 | Magellan |
| Biocomposites INC | $85.74 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $33.91 | 2025 | General - Pain Management |
| Amgen INC. | $18.37 | 2023 | Prolia, Evenity |
| Sanara Medtech INC. | $17.18 | 2023 | Celleraterx |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anuj Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.